StockData
AGTXOTCBiological Products, (No Diagnostic Substances)Fiscal year ends March 31

Agentix Corp.

Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$0.02+0.00 (0.00%)

Close on Oct 16, 2026

Market cap
$801.34K
P/E (TTM)
–
Dividend yield
–

Agentix statistics

Financials through Jun 30, 2026, price as of Oct 16, 2026, median of Biological Products, (No Diagnostic Substances) companies for comparison

Valuation

MeasureAgentixIndustry median
Market Cap$801.34K$164.85M
Enterprise Value$801.30K$87.06M

Income (trailing twelve months)

MeasureAgentixIndustry median
Operating Income-$340.35K-$21.44M
Pretax Income-$417.49K-$14.45M
Net Income-$417.49K-$22.46M
EBITDA-$340.35K-$16.91M
EPS (Diluted)$0.00-$0.83

Returns

MeasureAgentixIndustry median
Return on Assets (ROA)-18763.4%-41.0%

Balance sheet

MeasureAgentixIndustry median
Cash & Short-Term Investments$38$62.42M
Net Cash (Debt)$38$15.68M
Net Cash Per Share$0.00$0.66
Equity (Book Value)-$3.71M$48.79M
Book Value Per Share-$0.09$1.36
Tangible Book Value-$3.71M$23.06M
Working Capital-$3.71M$75.77M

Financial position

MeasureAgentixIndustry median
Current Ratio0.003.30
Quick Ratio0.002.39
Interest Coverage-4.20-7.12

Cash flow (trailing twelve months)

MeasureAgentixIndustry median
Operating Cash Flow-$16.53K-$12.35M

Dividends and yields

MeasureAgentixIndustry median
Earnings Yield-52.1%-22.7%

Shares

MeasureAgentixIndustry median
Shares Outstanding40,067,00058,179,650
Shares Change (YoY)0.00%11.1%
Shares Change (QoQ)0.00%0.54%
Float40,067,00049,173,100
Shares Held by Insiders0.00%11.6%

Taxes

MeasureAgentixIndustry median
Income Tax$0$91.50K

Scores

MeasureAgentixIndustry median
Altman Z-Score-409328-0.24
Piotroski F-Score24

Calculated by StockData from Agentix's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.